GSK-204958

Study Sponsor: GSK

Study Title

An open label, randomised, three arm, single dose, multicentre, parallel group study in healthy subjects to compare the pharmacokinetics of subcutaneous mepolizumab when delivered as a liquid drug product in a safety syringe or an auto injector with a reconstituted lyophilised drug product from a vial

Medicine or Vaccine (generic name)

mepolizumab

Sponsor Identification Number

204958

Trial Registry Identification Number(#'s)

NCT03014674 2016-002405-19

Medical Condition

Asthma

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=204958

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03014674

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2016-002405-19

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

September 2019